Jarol, Alkhalid P.

HRN: 18-60-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/10/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/10/2022
06/17/2022
IVT
401mg
Q6
Pcap C
Waiting Final Action 
09/11/2022
CEFUROXIME 1.5GM (VIAL)
09/11/2022
09/17/2022
IVT
433
Q8
Bacterial Infection T/c UTI
Waiting Final Action 
09/13/2022
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
09/13/2022
09/19/2022
PO
1ml
TID
Oral Ulcer
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: